|
Market Closed -
Nasdaq
16:00:00 2026-08-26 EDT
|
5-day change | 1st Jan Change | ||
| 0.8804 USD | +9.94% |
|
+13.16% | -20.68% |
| 08-20 | NexGel Files to Register 15.25 Million Shares From Note Conversions | MT |
| 08-07 | Celularity Inc Announces Termination of Rick Gonzalez from Chief Commercial Officer, Effective August 5, 2026 | CI |
| Market Cap | 25.48M 21.87M 20.53M 18.75M 35.39M 2.43B 35.56M 243M 94.16M 1.23B 95.68M 93.61M 4.06B | P/E 2024 |
-0.79x | P/E 2025 | -0.31x |
|---|---|---|---|---|---|
| Enterprise Value | 94.02M 80.7M 75.74M 69.18M 131M 8.97B 131M 896M 347M 4.52B 353M 345M 14.98B | EV / Sales 2024 |
2.12x | EV / Sales 2025 | 3.77x |
| Free-Float |
62.82% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +9.94% | ||
| 1 week | +13.16% | ||
| Current month | +38.58% | ||
| 1 month | +17.39% | ||
| 3 months | -1.84% | ||
| 6 months | -29.00% | ||
| Current year | -20.68% |
| 1 week | 0.73 |  | 1.11 |
| 1 month | 0.6 | | 1.11 |
| Current year | 0.56 | | 1.51 |
| 1 year | 0.56 | | 4 |
| 3 years | 0.56 | | 7.97 |
| 5 years | 0.56 | | 131.86 |
| 10 years | 0.56 | | 134 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 2015-12-31 | |
John Sprague
DFI | Director of Finance/CFO | 67 | 2026-02-26 |
K Fletcher
CMP | Compliance Officer | 42 | 2021-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 2015-12-31 | |
Peter Diamandis
BRD | Director/Board Member | 64 | 2017-06-30 |
Diane Parks
BRD | Director/Board Member | 73 | 2022-06-02 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/12/26 | Free | Director | 19,231 | 0.0667% | ||
| 1/12/26 | Free | Director | 30,000 | 0.1040% | ||
| 1/12/26 | Free | Director | 19,231 | 0.0667% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.94% | +13.16% | -77.60% | -70.51% | 25.48M | |
| -2.25% | -3.10% | +38.65% | -1.87% | 81.36B | |
| -5.77% | -14.18% | +505.18% | +33.71% | 59.75B | |
| +0.84% | +4.44% | -19.19% | -35.11% | 59.19B | |
| +0.76% | +3.53% | +0.08% | +36.18% | 53.33B | |
| +0.95% | +2.39% | +10.88% | +171.48% | 49.09B | |
| +0.14% | -0.22% | +61.70% | -16.40% | 32.66B | |
| -1.23% | -0.27% | +52.52% | +100.63% | 25.97B | |
| -2.00% | +6.32% | +18.24% | +209.64% | 24.39B | |
| +0.52% | +0.69% | +61.88% | +123.88% | 16.91B | |
| Average | +0.38% | +1.46% | +65.24% | +55.16% | 40.27B | |
| Weighted average by Cap. | -0.86% | -1.01% | +93.38% | +48.21% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 54.22M 46.54M 43.68M 39.89M 75.29M 5.17B 75.65M 517M 200M 2.61B 204M 199M 8.64B | 26.55M 22.79M 21.39M 19.53M 36.87M 2.53B 37.05M 253M 98.09M 1.28B 99.69M 97.52M 4.23B |
| Net income | -57.89M -49.69M -46.64M -42.6M -80.39M -5.52B -80.78M -552M -214M -2.79B -217M -213M -9.23B | -91.72M -78.72M -73.89M -67.48M -127M -8.75B -128M -874M -339M -4.41B -344M -337M -14.62B |
| Net Debt | 68.1M 58.45M 54.86M 50.11M 94.56M 6.5B 95.02M 649M 252M 3.28B 256M 250M 10.85B | 68.54M 58.83M 55.21M 50.43M 95.17M 6.54B 95.63M 653M 253M 3.3B 257M 252M 10.92B |
Employees
115
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-26 | US$0.8804 | +9.94% | 177,414 |
| 26-08-25 | US$0.8008 | +3.36% | 1,184,841 |
| 26-08-24 | US$0.7748 | -3.16% | 37,347 |
| 26-08-21 | US$0.8001 | +4.31% | 26,346 |
| 26-08-20 | US$0.7670 | -1.41% | 46,739 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CELU Stock
Select your edition
All financial news and data tailored to specific country editions
